Drs. Joe Neglia, Christopher Moertel and Jakub Tolar named Magazine's Top Doctors
January 10, 2010 | Three physicians conducting research supported by Children’s Cancer Research Fund receive high honor.
In a recent random poll of 2,500 local doctors and 2,500 nurses, three physicians conducting research supported by Children’s Cancer Research Fund, Drs. Neglia, Moertel and Tolar, were recognized as Mpls St.Paul Magazine's Top Doctors in the field of pediatric hematology and oncology.
Dr. Joe Neglia
Dr. Neglia serves on Children's Cancer Research Fund Board of Directors as a Medical Advisor. He is a Professor in the Division of Pediatric Hematology/Oncology/Blood and Marrow Transplantation at the University of Minnesota in Minneapolis and Section Chief of Pediatric Hematology/Oncology.
Dr. Neglia has been at the University of Minnesota since 1984 when he came to pursue a fellowship in Pediatric Hematology/Oncology and Blood and Marrow Transplantation.
Areas of research for Dr. Neglia include long-term effects of cancer therapy in cancer survivors and the occurrence of second malignancies following childhood cancer. He is nationally and internationally recognized for his contributions to the field of childhood cancer long-term effects. He is also adored and admired by his patients and colleagues.
Dr. Chris Moertel
Dr. Moertel is the director of the pediatric brain tumor program at University Minnesota Amplatz Children's Hospital. This program is the result of the collaborative effort by the Department of Pediatrics, the University of Minnesota Physicians, Fairview, and the Children's Cancer Research Fund. Moertel is a professor in the University of Minnesota Medical School's Department of Pediatrics, Division of Hematology/Oncology.
The Pediatric Neuro-Oncology Program is the first comprehensive research and treatment program in the Midwest and one of few such programs in the United States. Its purpose is twofold: conduct leading edge research on pediatric brain and spinal cord cancers and provide the most advanced treatment for children diagnosed with these conditions.
Dr. Moertel specializes in research and treatment of pediatric brain tumors, rare pediatric tumors, neurofibromatosis-associated neoplasia and therapy of children with brain and spinal cord tumors. Moertel has been named a Mpls/St.Paul Magazine Top Doc in at least five of the last seven surveys.
Dr. Jakub Tolar
Dr. Tolar is an Assistant Professor of Pediatrics at the University of Minnesota in the Division of Hematology-Oncology and Blood and Marrow Transplantation, and attends on both the Pediatric Hematology Oncology and the Pediatric Blood and Marrow Transplantation service.
Dr Tolar has been interested in the use of hematopoietic transplantation for bone marrow failure (e.g., aplastic anemia and dyskeratosis congenita) and metabolic disorders (e.g., mucopolysaccharidosis type I and adrenoleukodystrophy).
Dr. Tolar's research focuses on the use of bone marrow derived stem cells and Sleeping Beauty transposon gene therapy for correction of genetic diseases and improving outcome of blood and marrow transplantation.
Children's Cancer Research Fund extends its congratulations to Drs. Neglia, Moertel and Tolar for their deserving receipt of this honor.